The World Health Organization, the health agency of the United Nations, has officially recommended that cannabidiol (CBD) not be internationally scheduled as a controlled substance. WHO research on CBD’s therapeutic use and side effects found that the cannabinoid was not a public danger.
“Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions. Current evidence also shows that cannabidiol is not likely to be abused or create dependence as for other cannabinoids (such as Tetra Hydro Cannabinol (THC), for instance),” reads an announcement from the WHO Expert Committee on Drug Dependence.
CBD has shown that it has medical benefits for epileptic seizures, pain, insomnia and inflammation, among other afflictions; it can be derived from both psychoactive cannabis and hemp. According to the WHO report, there is also preliminary evidence that it can treat Alzheimer’s disease, Crohn’s disease, certain forms of cancer, Parkinson’s disease and other serious conditions.